Frontiers in Pharmacology
Weight-gain-related reporting for anti-obesity medications compared to tirzepatide in United States Food and Drug Administration Adverse Event Reporting System (FAERS)
Accepted, not yet published: cross-sectional study of 65,719 peopleObesity



![Classification of obesity.[38] BMI: Body mass index](/_next/image?url=%2Ffig%2FMED-42683980%2Ff5fa9110.webp&w=1600&q=75&dpl=a2f5682e30d6)